FDA Eyes More Pre-ANDA Meetings to Speed Approval Process

A A
The FDA intends to grant more drugmaker requests for pre-ANDA meetings as a way to work with industry to ensure quality ANDA submissions, FDA officials say.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00